NCT03956836View on ClinicalTrials.gov

Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

March 27, 2020

Primary Completion Date

March 8, 2021

Study Completion Date

March 8, 2021

Conditions
Coagulation DisorderCarcinomatosis
Interventions
DIAGNOSTIC_TEST

ROTEM parameters, platelet function assay (PFA-100), von Willebrand and Factor XIII

ROTEM parameters, platelet function assay (PFA-100), von Willebrand and Factor XIII at baseline (before surgery) and after 4h and 48 after surgery in 40 patients undergoing CRC

Trial Locations (1)

41012

Hospital Universitario Virgen del Rocio, Seville

All Listed Sponsors
lead

Hospitales Universitarios Virgen del Rocío

OTHER

NCT03956836 - Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC) | Biotech Hunter | Biotech Hunter